Update on Flow Cytometry: Leukaemia and Immunotherapy

Share post on social media:
Update on Flow Cytometry: Leukaemia and Immunotherapy

In this webinar Jordi Petriz will discuss state-of-the-art flow technology and its impact on Immunotherapy and Leukemia evaluations. Functional Cytomics allow for the discovery and characterization of new cell subpopulations, mechanisms of resistance to immunotherapy and chemotherapy; and multiplexed evaluations for detecting malignant clones at a single-cell level.

 

You might also like...

View blog
EuroFlow™ Primary Immunodeficiency panels: a powerful tool for diagnostic patient care
0 min read
EuroFlow™ Primary Immunodeficiency panels: a powerful tool for diagnostic patient care
Primary immunodeficiencies (PID) are hereditary disorders where cell types can be absent, decreased or dysfunctional. The majority of PID...
Impact of Standardized Flow Cytometry Protocols on the Diagnostic Accuracy of Acute Leukemias
0 min read
Impact of Standardized Flow Cytometry Protocols on the Diagnostic Accuracy of Acute Leukemias
Acute leukemia is a heterogeneous group of disease reflecting stem cell of origin, capacity of maturation and commitment to a specific...
Capabilities of the flow cytometric OX40 assay to determine specific SARS-CoV-2 T cell responses
1 min read
Capabilities of the flow cytometric OX40 assay to determine specific SARS-CoV-2 T cell responses
The adaptive immune response to SARS-CoV-2 includes specific antibody and T cell responses. The identification of a subpopulation of...